The Food and Drug Administration has expanded the age limitations for the following vaccines:
- Vaxneuvance™ (pneumococcal 15-valent conjugate vaccine), procedure code 90671, to be used in individuals 6 weeks of age or older
- Flucelvax® Quadrivalent (influenza vaccine), procedure code 90756, to be used in individuals 6 months of age or older
Effective February 1, 2023, for dates of service on or after December 1, 2022, the age limitations for vaccine procedure codes will be expanded as follows:
- Procedure code 90671: individuals 6 weeks of age or older
- Procedure code 90756: individuals 6 months of age or older
Note: Procedure codes for vaccines distributed by the Texas Vaccines for Children Program are processed as Informational on Texas Medicaid fee-for-service claims for clients 18 years of age or younger. However, these procedure codes are reported with the procedure code for the administration of the vaccine, which allows the provider to be reimbursed for the administration service.
Providers may bill MCOs retroactively for vaccine procedure codes 90671 and 90756 for individuals 6 weeks or older and 6 months or older, respectively.
Contact:
Email ProviderRelations@cfhp.com or call 210-358-6294.